KALA BIO launches AI infrastructure platform; licenses Researgency from Younet AI

KALA BIO, Inc.

Exclusive worldwide license to Researgency platform for biotech field; initial 12-month term with renewal options.
Consideration includes up to $530k cash and issuance of 5 million shares of KALA common stock per term.
Company holds an irrevocable option to acquire Younet AI for $55 million, exercisable during the term.
Strategic pivot: KALA will deploy on-premises, data-sovereign AI for biotech clients targeting recurring revenue.
KALA will first deploy on its own MSC-S and KPI-012 data; preliminary findings expected in 12 months.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

KALA BIO, Inc. issued 5,000,000 shares of the Company’s common stock of common stock to 2624465 Ontario Inc. o/a Younet AI for up to $530,000 in cash, of which $80,000 paid on Effective Date, and up to $450,000 additional.

Security: common stock
Shares: 5,000,000 shares of the Company’s common stock
Purchaser: 2624465 Ontario Inc. o/a Younet AI
Consideration: up to $530,000 in cash, of which $80,000 paid on Effective Date, and up to $450,000 additional

Exact text from the filing

by the Company. In consideration of the services to be performed by Younet under the Agreement, the Company has agreed to pay to Younet for the Initial Term a cash fee of up to $530,000 consisting of (i) $80,000 in cash, which was paid by the Company on the Effective Date, and (ii) in the event the Company delivers to Younet a written notice electing to engage

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

KALA BIO, Inc. entered into Agreement with 2624465 Ontario Inc. o/a Younet AI (effective 2026-03-03).

Action: entry
Agreement: license
Counterparty: 2624465 Ontario Inc. o/a Younet AI
Effective: 2026-03-03

Exact text from the filing

On March 3, 2026 (the “Effective Date”), KALA BIO, Inc. (the “Company”) and 2624465 Ontario Inc. o/a Younet AI, an Ontario corporation (“Younet”) entered into a Platform Development and Exclusive License Agreement (the “Agreement”)

View on SEC.gov

17 equity issuances filed in the last 30 days. Browse all equity issuances →

KALA BIO, Inc. filing history →

Source: SEC EDGAR

accession 0001829126-26-001911

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.